查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1957289

體外膜氧合（ECMO）設備市場－全球產業規模、佔有率、趨勢、機會、預測：按組件類型、模式、病患類型、應用、地區和競爭格局分類，2021-2031年

Extracorporeal Membrane Oxygenation Machine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component Type, By Modality, By Patient Type, By Application, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球體外膜氧合（ECMO）設備市場預計將從 2025 年的 4.4163 億美元成長到 2031 年的 5.9692 億美元，複合年成長率為 5.15%。

體外膜氧合（ECMO）設備作為重要的維生系統，為心肺功能受損的患者提供長期的呼吸和心臟輔助。市場成長的主要促進因素包括嚴重心血管和呼吸系統疾病（例如急性呼吸窘迫症候群）發病率的上升，以及老齡化人口對高階重症監護解決方案的需求不斷成長。根據體外生命支持組織（ELSO）的數據，到2024年，註冊患者人數將超過20萬，這表明該療法在治療危及生命的健康問題方面正得到越來越廣泛的應用。

市場概覽
預測期 2027-2031
市場規模：2025年 4.4163億美元
市場規模：2031年 5.9692億美元
複合年成長率：2026-2031年 5.15%
成長最快的細分市場 泵浦
最大的市場 北美洲

儘管需求強勁，但體外膜氧合（ECMO）治療費用高昂，且有感染疾病和出血等臨床風險，這些都構成了重大障礙。此外，ECMO還需要專門的基礎設施和進階培訓，這些挑戰嚴重阻礙了ECMO的廣泛應用，尤其是在缺乏充足資金和技術專長的醫療機構中。

市場促進因素

呼吸系統和心血管疾病發生率的不斷上升是全球體外膜氧合（ECMO）設備市場成長的主要驅動力。隨著急性呼吸窘迫症候群和心臟衰竭等疾病發病率的不斷攀升，臨床上對機械循環支持的需求日益迫切。其影響十分顯著；根據美國心臟協會於2024年1月發布的《2024年心臟病和中風統計數據》，約48.6%的美國成年人將患有某種形式的心血管疾病。這一現實迫使醫療機構採用先進的生命維持系統來滿足不斷成長的患者群體，並加速了ECMO作為移植和復健關鍵橋樑的需求。

同時，體外心肺復甦術（CPR）技術的日益普及和專業重症監護設施的擴建也支撐著市場的發展勢頭。這一上升趨勢反映在主要市場參與企業的財務表現中，顯示設備使用量整體呈現成長趨勢。例如，Livanova在2024年5月發布的2024年第一季財報中顯示，其心肺復甦部門的營收年增14.8%，顯示這些治療方法得到了迅速推廣。更廣泛的行業數據也印證了這一成長趨勢。 Terumo Terumo Corporation在2024年5月發布的截至2024年3月的會計年度合併會計顯示，其總收入同比成長12.4%，凸顯了其商業規模的擴大以及對這些關鍵醫療技術的持續投資。

市場挑戰

體外膜氧合（ECMO）療法的高昂成本和顯著的臨床風險是限制全球市場擴張的主要障礙。醫療機構不僅需要承擔購買這些先進設備的巨額費用，還需要資金籌措來維護專業設施和高技能的多學科團隊。這些經濟障礙使得小規模、資源有限的醫療機構幾乎無法採用這項技術，導致該市場主要局限於大型醫療機構。

此外，由於嚴重併發症發生率高，這種療法仍是最後的選擇，而非標準治療方案。近期數據凸顯了高風險患者族群生存保障的挑戰，也強調了臨床療效的不穩定性。根據體外生命支持系統（ELSO）2024年發布的國際註冊報告，接受體外心肺復甦術的成年患者的出院存活率僅29.5%。如此低的生存率進一步強化了該手術風險極高的觀點，促使臨床醫生在選擇患者時更加謹慎，從而導致全球範圍內手術數量減少。

市場趨勢

輕量、緊湊、可攜式膜氧合（ECMO）系統的研發正在從根本上改變市場格局。這使得高級生命支持能夠突破固定三級醫療機構的限制。這些小型化設備能夠安全地在醫院間轉運嚴重病人，並有效實施「中心輻射式」模式，即由小規模醫療機構先穩定病人病情，然後再將其轉運至專科醫院。這種向便攜化發展的趨勢解決了傳統大規模主機在運輸方面面臨的挑戰，並拓展了現場應用範圍和地理覆蓋範圍。美國外科醫師學會於2025年9月發表的一篇報導《ECMO：從罕見的救命選擇到切實可行的方案》的文章指出，一項美國計畫調查發現，在274家成人ECMO中心中，目前有63家提供行動服務，這表明醫療機構正在迅速投資於運輸基礎設施，以改善患者的醫療就途徑。

同時，人工智慧 (AI) 在即時預測分析中的應用正在透過提高臨床決策的準確性，徹底改變患者照護。製造商正在加速將機器學習演算法整合到體外膜氧合 (ECMO) 設備中，以解讀複雜的生理數據，從而在氧合器故障和血栓形成等併發症發展到危險階段之前，儘早識別它們。這項技術進步正在將治療模式從被動的、以維持為主的治療方法轉變為主動的、精準的醫療策略，從而直接應對與該手術相關的高死亡風險。 Integration Health 在 2025 年 4 月發布的報告《人工智慧與 ECMO：重症監護死亡率預測的未來》中強調了這一潛力，該報告指出，經過檢驗的AI 模型在預測靜脈-動脈 ECMO 患者 28 天死亡風險方面達到了 93% 以上的準確率，為臨床醫生提供了一個強大的工具，用於最佳化治療方案和患者選擇。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：體外膜氧合裝置的全球市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依組件類型（幫浦、氧合器、控制器、插管、附件）
    • 特定模式（靜脈-動脈、靜脈-靜脈、動脈-靜脈）
    • 依患者類型（新生兒、兒童、成人）
    • 依應用領域（呼吸系統、心臟系統、體外心肺復甦術）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美體外膜氧合（ECMO）設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲體外膜氧合設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區體外膜氧合設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲體外膜氧合設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲體外膜氧合設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章 全球體外膜氧合（ECMO）設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • India Medtronic Private Limited
  • Terumo Cardiovascular Systems Corporation
  • MAQUET Holding BV & Co. KG
  • Medos Medizintechnik AG
  • Nipro Medical Corporation
  • MicroPort Scientific Corporation
  • XENIOS AG
  • LivaNova PLC
  • EUROSETS Srl

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23773

The Global Extracorporeal Membrane Oxygenation Machine Market is projected to expand from USD 441.63 Million in 2025 to USD 596.92 Million by 2031, registering a compound annual growth rate of 5.15%. An Extracorporeal Membrane Oxygenation (ECMO) machine functions as a critical life-support apparatus, offering extended respiratory and cardiac assistance to patients with compromised heart and lung function. Market growth is chiefly driven by the increasing incidence of severe cardiovascular and respiratory conditions, such as acute respiratory distress syndrome, coupled with an aging demographic that demands advanced critical care solutions. Data from the Extracorporeal Life Support Organization reveals that by 2024, the registry had cumulatively enrolled more than 200,000 patients, highlighting the broadening adoption of this therapy for life-threatening health issues.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 441.63 Million
Market Size 2031USD 596.92 Million
CAGR 2026-20315.15%
Fastest Growing SegmentPumps
Largest MarketNorth America

Despite this robust demand, the market encounters substantial obstacles related to the significant expenses and clinical dangers associated with ECMO interventions, including infection and hemorrhage. When coupled with the requirement for specialized infrastructure and extensive training, these issues form major impediments to widespread adoption, especially in medical facilities lacking significant financial capability or technical proficiency.

Market Driver

The escalating frequency of respiratory and cardiovascular disorders acts as the main engine for growth in the Global Extracorporeal Membrane Oxygenation Machine Market. With the rising occurrence of ailments like acute respiratory distress syndrome and heart failure, the clinical requirement for mechanical circulatory support is becoming increasingly urgent. The impact is significant; the American Heart Association's 'Heart Disease and Stroke Statistics-2024 Update' from January 2024 reveals that approximately 48.6% of adults in the United States suffer from some type of cardiovascular disease. This reality forces healthcare institutions to adopt sophisticated life-support systems to treat this expanding patient demographic, thereby stimulating the need for ECMO as a crucial bridge to transplantation or recovery.

Concurrently, market momentum is being sustained by the growing implementation of extracorporeal cardiopulmonary resuscitation and the broadening of specialized critical care facilities. This upward trend is mirrored in the financial results of key market participants, indicating a general increase in device usage. For example, LivaNova reported in its 'First Quarter 2024 Results' in May 2024 that revenue for its Cardiopulmonary division rose by 14.8% year-over-year, demonstrating the rapid adoption of these treatments. This expansion is further supported by broader industry figures; Terumo Corporation's 'Consolidated Financial Results for the Fiscal Year Ended March 31, 2024', released in May 2024, showed a 12.4% annual increase in total revenue, emphasizing the substantial commercial scale and ongoing investment in these essential care technologies.

Market Challenge

The significant financial expenses and considerable clinical dangers linked to Extracorporeal Membrane Oxygenation procedures act as major impediments to the global market's expansion. Medical centers must contend with heavy costs, not only for the initial purchase of these sophisticated devices but also for the continuous funding required for specialized facilities and highly skilled multidisciplinary teams. These economic barriers effectively prevent resource-constrained or smaller healthcare institutions from adopting the technology, consequently limiting the market's potential client base primarily to large medical hubs.

Additionally, the frequency of severe complications restricts the use of this therapy to a measure of last resort rather than a standard option. The volatility of clinical outcomes is underscored by recent data showing the challenges in securing survival among high-risk patient cohorts. As per the Registry International Report released by the Extracorporeal Life Support Organization in 2024, the survival-to-discharge rate for adults undergoing extracorporeal cardiopulmonary resuscitation was merely 29.5 percent. Such modest survival rates solidify the view of the procedure as a precarious undertaking, prompting clinicians to be extremely selective with patients, which ultimately suppresses the global volume of procedures.

Market Trends

The market is undergoing a fundamental transformation due to the development of lightweight, compact transportable ECMO systems, which allow advanced life support to extend beyond stationary tertiary care environments. These miniaturized units enable the safe transfer of critically ill patients between hospitals, effectively implementing a "hub-and-spoke" model where smaller clinics can stabilize patients prior to moving them to specialized facilities. This evolution toward portability resolves the logistical challenges posed by older, bulky consoles, broadening the technology's application in the field and its geographic reach. According to an article by the American College of Surgeons titled 'ECMO Expands from Rare Rescue to Real Option' in September 2025, a survey of U.S. programs indicated that 63 out of 274 adult ECMO centers now provide mobile services, signifying rapid investment in transport infrastructure to enhance patient access.

At the same time, the incorporation of artificial intelligence for real-time predictive analytics is revolutionizing patient care by improving the precision of clinical decisions. Manufacturers are increasingly integrating machine learning algorithms into ECMO devices to interpret complex physiological data, allowing for the early identification of complications like oxygenator failure or clot formation before they reach a critical stage. This technological advancement transitions the therapy from a reactive maintenance approach to a proactive precision medicine strategy, directly addressing the high mortality risks linked to the procedure. This potential was highlighted by Integration Health in their April 2025 report 'AI and ECMO: The Future of Mortality Prediction in Critical Care', which noted that a validated AI model achieved over 93% accuracy in predicting 28-day mortality risk in Veno-Arterial ECMO patients, providing clinicians with a robust tool for optimizing care plans and patient selection.

Key Market Players

  • India Medtronic Private Limited
  • Terumo Cardiovascular Systems Corporation
  • MAQUET Holding B.V. & Co. KG
  • Medos Medizintechnik AG
  • Nipro Medical Corporation
  • MicroPort Scientific Corporation
  • XENIOS AG
  • LivaNova PLC
  • EUROSETS S.r.l.

Report Scope

In this report, the Global Extracorporeal Membrane Oxygenation Machine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Extracorporeal Membrane Oxygenation Machine Market, By Component Type

  • Pumps
  • Oxygenator
  • Controllers
  • Cannula
  • Accessories

Extracorporeal Membrane Oxygenation Machine Market, By Modality

  • Veno-Arterial
  • Veno-Venous
  • Arterio-Venous

Extracorporeal Membrane Oxygenation Machine Market, By Patient Type

  • Neonates
  • Pediatric
  • Adult

Extracorporeal Membrane Oxygenation Machine Market, By Application

  • Respiratory
  • Cardiac
  • ECPR

Extracorporeal Membrane Oxygenation Machine Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Extracorporeal Membrane Oxygenation Machine Market.

Available Customizations:

Global Extracorporeal Membrane Oxygenation Machine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Extracorporeal Membrane Oxygenation Machine Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component Type (Pumps, Oxygenator, Controllers, Cannula, Accessories)
    • 5.2.2. By Modality (Veno-Arterial, Veno-Venous, Arterio-Venous)
    • 5.2.3. By Patient Type (Neonates, Pediatric, Adult)
    • 5.2.4. By Application (Respiratory, Cardiac, ECPR)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Extracorporeal Membrane Oxygenation Machine Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component Type
    • 6.2.2. By Modality
    • 6.2.3. By Patient Type
    • 6.2.4. By Application
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component Type
        • 6.3.1.2.2. By Modality
        • 6.3.1.2.3. By Patient Type
        • 6.3.1.2.4. By Application
    • 6.3.2. Canada Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component Type
        • 6.3.2.2.2. By Modality
        • 6.3.2.2.3. By Patient Type
        • 6.3.2.2.4. By Application
    • 6.3.3. Mexico Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component Type
        • 6.3.3.2.2. By Modality
        • 6.3.3.2.3. By Patient Type
        • 6.3.3.2.4. By Application

7. Europe Extracorporeal Membrane Oxygenation Machine Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component Type
    • 7.2.2. By Modality
    • 7.2.3. By Patient Type
    • 7.2.4. By Application
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component Type
        • 7.3.1.2.2. By Modality
        • 7.3.1.2.3. By Patient Type
        • 7.3.1.2.4. By Application
    • 7.3.2. France Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component Type
        • 7.3.2.2.2. By Modality
        • 7.3.2.2.3. By Patient Type
        • 7.3.2.2.4. By Application
    • 7.3.3. United Kingdom Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component Type
        • 7.3.3.2.2. By Modality
        • 7.3.3.2.3. By Patient Type
        • 7.3.3.2.4. By Application
    • 7.3.4. Italy Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component Type
        • 7.3.4.2.2. By Modality
        • 7.3.4.2.3. By Patient Type
        • 7.3.4.2.4. By Application
    • 7.3.5. Spain Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component Type
        • 7.3.5.2.2. By Modality
        • 7.3.5.2.3. By Patient Type
        • 7.3.5.2.4. By Application

8. Asia Pacific Extracorporeal Membrane Oxygenation Machine Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component Type
    • 8.2.2. By Modality
    • 8.2.3. By Patient Type
    • 8.2.4. By Application
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component Type
        • 8.3.1.2.2. By Modality
        • 8.3.1.2.3. By Patient Type
        • 8.3.1.2.4. By Application
    • 8.3.2. India Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component Type
        • 8.3.2.2.2. By Modality
        • 8.3.2.2.3. By Patient Type
        • 8.3.2.2.4. By Application
    • 8.3.3. Japan Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component Type
        • 8.3.3.2.2. By Modality
        • 8.3.3.2.3. By Patient Type
        • 8.3.3.2.4. By Application
    • 8.3.4. South Korea Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component Type
        • 8.3.4.2.2. By Modality
        • 8.3.4.2.3. By Patient Type
        • 8.3.4.2.4. By Application
    • 8.3.5. Australia Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component Type
        • 8.3.5.2.2. By Modality
        • 8.3.5.2.3. By Patient Type
        • 8.3.5.2.4. By Application

9. Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component Type
    • 9.2.2. By Modality
    • 9.2.3. By Patient Type
    • 9.2.4. By Application
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component Type
        • 9.3.1.2.2. By Modality
        • 9.3.1.2.3. By Patient Type
        • 9.3.1.2.4. By Application
    • 9.3.2. UAE Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component Type
        • 9.3.2.2.2. By Modality
        • 9.3.2.2.3. By Patient Type
        • 9.3.2.2.4. By Application
    • 9.3.3. South Africa Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component Type
        • 9.3.3.2.2. By Modality
        • 9.3.3.2.3. By Patient Type
        • 9.3.3.2.4. By Application

10. South America Extracorporeal Membrane Oxygenation Machine Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component Type
    • 10.2.2. By Modality
    • 10.2.3. By Patient Type
    • 10.2.4. By Application
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component Type
        • 10.3.1.2.2. By Modality
        • 10.3.1.2.3. By Patient Type
        • 10.3.1.2.4. By Application
    • 10.3.2. Colombia Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component Type
        • 10.3.2.2.2. By Modality
        • 10.3.2.2.3. By Patient Type
        • 10.3.2.2.4. By Application
    • 10.3.3. Argentina Extracorporeal Membrane Oxygenation Machine Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component Type
        • 10.3.3.2.2. By Modality
        • 10.3.3.2.3. By Patient Type
        • 10.3.3.2.4. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Extracorporeal Membrane Oxygenation Machine Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. India Medtronic Private Limited
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Terumo Cardiovascular Systems Corporation
  • 15.3. MAQUET Holding B.V. & Co. KG
  • 15.4. Medos Medizintechnik AG
  • 15.5. Nipro Medical Corporation
  • 15.6. MicroPort Scientific Corporation
  • 15.7. XENIOS AG
  • 15.8. LivaNova PLC
  • 15.9. EUROSETS S.r.l.

16. Strategic Recommendations

17. About Us & Disclaimer